Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma

Leuk Lymphoma. 2016 Dec;57(12):2914-2916. doi: 10.3109/10428194.2016.1169408. Epub 2016 Apr 18.

Authors

Hun Ju Lee¹, Dai Chihara¹, Michael Wang¹, Elie Mouhayar², Peter Kim²

Affiliations

¹ a Department of Lymphoma & Myeloma , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
² b Department of Cardiology , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.

PMID: 27087288
DOI: 10.3109/10428194.2016.1169408

No abstract available

Publication types

Letter

MeSH terms

Adenine / analogs & derivatives
Aged
Aged, 80 and over
Atrial Fibrillation / chemically induced*
Atrial Fibrillation / epidemiology*
Female
Follow-Up Studies
Humans
Incidence
Lymphoma, Mantle-Cell / drug therapy*
Lymphoma, Mantle-Cell / epidemiology
Male
Piperidines
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Recurrence
Retrospective Studies
Treatment Outcome

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine